Autocrine Growth Factors and Neuroendocrine Markers in the Development of Small-Cell Lung Cancer

ONCOLOGY

Volumn 12, Issue 1 SUPPL. 2, 1998, Pages 11-14

  Johnson, Bruch E ^a   Kelley, Michael J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; GASTRIN RELEASING PEPTIDE; IMMUNOTOXIN; MONOCLONAL ANTIBODY; N901 MOAB BLOCKED RICIN CONJUGATE; N901 MOAB-BLOCKED RICIN CONJUGATE; NERVE CELL ADHESION MOLECULE; RICIN;

ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; IMMUNOLOGY; LUNG TUMOR; MALE; PHASE 2 CLINICAL TRIAL; RADIOGRAPHY; SMALL CELL CARCINOMA;

ANTIBODIES, MONOCLONAL; CARCINOMA, SMALL CELL; FEMALE; GASTRIN-RELEASING PEPTIDE; HUMANS; IMMUNOTOXINS; LUNG NEOPLASMS; MALE; NEURAL CELL ADHESION MOLECULES; RICIN;

EID: 0008382667     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Johnson BE: Biology and molecular genetics of lung cancer Semin Respir Crit Care Med 17:299-308, 1996.
2. Lynch TJ, Lambert JM, Coral F, et al: Immunotoxin therapy of small-cell lung cancer: A phase I study of N901-blocked ricin. J clin Oncol 15:723-734, 1997.
3. Kelley MJ, Linnoila RI, Avis IL, et al: Antitumor activity of a monoclonal antibody directed against gastrin-releasing peptide in patients with small cell lung cancer. Chest 112:256-261, 1997.
4. Sporn MB, Todaro GJ: Autocrine secretion and malignant transformation of cells. N Engl J Med 303:878-880, 1980
5. Cuttitta F, Carney DN, Mulshme J, et al: Bombesin-hke peptides can function as autocnne growth factors in human small-cell lung cancer. Nature 316:123-126, 1985.
6. Rutishauser U, Acheson A, Hall AK, et al: The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions. Science 240:53-57, 1988
7. Cunningham B A, Hemperly JJ, Murray BA, et al: Neural cell adhesion molecule: Structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing. Science 236:799-806, 1987.
8. Doria MI, Montag AG, Franklin WA: Immunophenotype of small cell lung carcinoma: Expression of NKH-1 and transferrin receptor and absence of most myeloid antigens. Cancer 62:1939-1945, 1988.
9. Carbone DP, Koros AMC, Linnoila RI, et al: Neural cell adhesion molecule expression and mRNA splicing patterns in lung cancer cell lines are correlated with neuroendocrine phenotype and growth morphology. Cancer Res 51:6142-6149, 1991.
10. Lambert JM, McIntyre G, Gautheir, MN, et al: The galactose-binding sites of the cytotoxic lectin ricin can be chemically blocked in high yield with reactive Iigands prepared by chemical modification of glycopeptides containing triantennary N-linked oligosaccharides. Biochemistry 30:3234-3247, 1991
11. Johnson BE, Bridges JD, Sobczeck M, et al: Patients with limited stage small cell lung cancer treated with concurrent twice daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide. doxorubicin, and vincristine. J Clin Oncol 14:806-813, 1996.
12. Avis IL, Kovacs TO, Kasprzyk PG, et al: Preclinical evaluation of an anti-autocrine growth factor monoclonal antibody for treatment of patients with small-cell iung cancer. J Natl Cancer Inst 83:1470-1476, 1991.
13. Mulshine JL, Avis I, Treston AM, et al: Clinical use of a monoclonal antibody to bombesin-like peptide in patients with lung cancer. Ann NY Acad Sci 547:360-372, 1988.
14. Mulshine J, Avis I, Carrasquillo J, et al: Phase I study of an anti-gastrin releasing peptide monoclonal antibody in patients with lung cancer (abstract). Proc Am Soc Clin Oncol 9:230, 1990.